October 31, 2018
FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
Read more here…
October 31, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use.
Read more here…
October 30, 2018
FDA takes action to stop the use of lead acetate in hair dyes. FDA will no longer allow lead acetate to be used in certain hair coloring products based on data that demonstrate that there is no longer a reasonable certainty of no harm from the use of this color additive.
Read more here…
October 30, 2018
FDA announces new plan to advance the development of plant and animal biotechnology innovation
Read more here…
October 29, 2018
Food allergies have touched the lives of most of us. Thousands of Americans experience life-threatening, food-related reactions each year, and an estimated 20 people die from them annually. In some cases, such reactions occur despite a careful reading of packaged food labels by conscientious consumers. To me, that’s unacceptable. The FDA is committed to advancing […]
Read more here…
October 24, 2018
FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
Read more here…
October 24, 2018
The SUPPORT Act grants FDA additional authorities to meaningfully advance efforts to combat the crisis of opioid addiction plaguing our nation.
Read more here…
October 24, 2018
FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours.
Read more here…
October 23, 2018
A federal court orders a Tennessee-based company to stop selling over-the-counter (OTC) drug products
Read more here…
October 23, 2018
FDA warns website networks as part of global crack down for selling illegal pharmaceuticals
Read more here…
October 23, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths
Read more here…
October 22, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.
Read more here…
October 19, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, fresh-cut produce processors more effectively comply with food safety requirements
Read more here…
October 18, 2018
The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the “Winning on Reducing Food Waste” initiative.
Read more here…
October 16, 2018
FDA and DHS announce partnership to address medical device cybersecurity threats
Read more here…
October 15, 2018
FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.
Read more here…
October 12, 2018
FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency’s compliance policy
Read more here…
October 11, 2018
FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results
Read more here…
October 9, 2018
FDA issued a new series of guidance documents that will advance the development of generic transdermal and topical delivery systems
Read more here…